Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts

Xenotransplantation

Volumn 22, Issue 1, 2015, Pages 48-61

  Wang, Yujia ^a   Bao, Ji ^a   Wu, Qiong ^a   Zhou, Yongjie ^a   Li, Yi ^a   Wu, Xiujuan ^b   Shi, Yujun ^a   Li, Li ^a   Bu, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

decellularization; extracellular matrix; porcine; tissue engineering; xenotransplantation

Indexed keywords

DEOXYCHOLATE SODIUM; DODECYL SULFATE SODIUM; PERACETIC ACID; TRITON X 100; DEOXYCHOLIC ACID; DETERGENT; DNA; MEMBRANE PROTEIN; OCTOXINOL;

ANIMAL TISSUE; ARTICLE; BIOENGINEERING; CELL COMPONENT; CONTROLLED STUDY; DECELLULARIZATION; EXTRACELLULAR MATRIX; IMMUNOCHEMISTRY; KIDNEY PERFUSION; LIVER PERFUSION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SWINE; TISSUE GRAFT; TISSUE SCAFFOLD; ANATOMY AND HISTOLOGY; ANIMAL; BASEMENT MEMBRANE; CHEMISTRY; DRUG EFFECTS; KIDNEY; KIDNEY ARTERY; LIVER; MALE; MINIPIG; PERFUSION; PIG; PORTAL VEIN; PROCEDURES; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; BASEMENT MEMBRANE; BIOENGINEERING; DEOXYCHOLIC ACID; DETERGENTS; DNA; EXTRACELLULAR MATRIX; KIDNEY; LIVER; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, SCANNING; OCTOXYNOL; PERACETIC ACID; PERFUSION; PORTAL VEIN; RENAL ARTERY; SODIUM DODECYL SULFATE; SWINE; SWINE, MINIATURE; TISSUE SCAFFOLDS;

EID: 84922636104     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12141     Document Type: Article

References (46)

1. Sites AH, Deliver H, Care A, et al. Health resources and services administration. Target 2006; 256: 832-1000.
2. Crapo PM, Gilbert TW, Badylak SF,. An overview of tissue and whole organ decellularization processes. Biomaterials 2011; 32: 3233-3243.
3. Gilbert TW, Sellaro TL, Badylak SF,. Decellularization of tissues and organs. Biomaterials 2006; 27: 3675-3683.
4. Nelson CM, Bissell MJ,. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2006; 22: 287-309.
5. Vorotnikova E, McIntosh D, Dewilde A, et al. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo. Matrix Biol 2010; 29: 690-700.
6. Barkan D, Green JE, Chambers AF,. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer 2010; 46: 1181-1188.
7. Kolker AR, Brown DJ, Redstone JS, et al. Multilayer reconstruction of abdominal wall defects with acellular dermal allograft (AlloDerm) and component separation. Ann Plast Surg 2005; 55: 36-41; discussion 41-32.
8. Wainwright D,. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 1995; 21: 243-248.
9. El Kassaby A, AbouShwareb T, Atala A,. Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol 2008; 179: 1432-1436.
10. Ott HC, Matthiesen TS, Goh S-K, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008; 14: 213-221.
11. Lichtenberg A, Tudorache I, Cebotari S, et al. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 2006; 114 (1 Suppl): I559-I565.
12. Barakat O, Abbasi S, Rodriguez G, et al. Use of decellularized porcine liver for engineering humanized liver organ. J Surg Res 2012; 173: e11-e25.
13. Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010; 16: 814-820.
14. Ferguson RE Jr, Pu LL,. Repair of the abdominal donor-site fascial defect with small intestinal submucosa (Surgisis) after TRAM flap breast reconstruction. Ann Plast Surg 2007; 58: 95-98.
15. Nakayama KH, Batchelder CA, Lee CI, et al. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng Part A 2010; 16: 2207-2216.
16. Hülsmann J, Grün K, El Amouri S, et al. Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing. Xenotransplantation 2012; 19: 286-297.
17. Petersen TH, Calle EA, Zhao L, et al. Tissue-engineered lungs for in vivo implantation. Science 2010; 329: 538-541.
18. Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010; 16: 927-933.
19. Fox IJ, Roy-Chowdhury J,. Hepatocyte transplantation. J Hepatol 2004; 40: 878-886.
20. Kim SS, Sundback CA, Kaihara S, et al. Dynamic seeding and in vitro culture of hepatocytes in a flow perfusion system. Tissue Eng 2000; 6: 39-44.
21. Gilbert TW, Wognum S, Joyce EM, et al. Collagen fiber alignment and biaxial mechanical behavior of porcine urinary bladder derived extracellular matrix. Biomaterials 2008; 29: 4775-4782.
22. Sasaki S, Funamoto S, Hashimoto Y, et al. In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas. Mol Vis 2009; 15: 2022-2028.
23. Grant R,. Estimation of hydroxyproline by the autoanalyser. J Clin Pathol 1964; 17: 685.
24. Park K-M, Park S-M, Yang S-R, et al. Preparation of immunogen-reduced and biocompatible extracellular matrices from porcine liver. J Biosci Bioeng 2013; 115: 207-215.
25. Freytes DO, Badylak SF, Webster TJ, et al. Biaxial strength of multilaminated extracellular matrix scaffolds. Biomaterials 2004; 25: 2353-2361.
26. Dahl SL, Koh J, Prabhakar V, et al. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 2003; 12: 659-666.
27. Cartmell JS, Dunn MG,. Effect of chemical treatments on tendon cellularity and mechanical properties. J Biomed Mater Res 2000; 49: 134-140.
28. Woods T, Gratzer PF,. Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft. Biomaterials 2005; 26: 7339-7349.
29. Badylak SF, Gilbert TW,. Immune Response to Biologic Scaffold Materials. Seminars in Immunology. Amsterdam: Elsevier, 2008: 109-116.
30. Rieder E, Kasimir M-T, Silberhumer G, et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 2004; 127: 399-405.
31. Cooper DK,. Xenoantigens and xenoantibodies. Xenotransplantation 1998; 5: 6-17.
32. Ezzelarab M, Cooper DK,. Reducing Gal expression on the pig organ-a retrospective review. Xenotransplantation 2005; 12: 278-285.
33. Stone KR, Abdel-Motal UM, Walgenbach AW, et al. Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation 2007; 83: 211-219.
34. Naso F, Gandaglia A, Iop L, et al. Alpha-Gal detectors in xenotransplantation research: a word of caution. Xenotransplantation 2012; 19: 215-220.
35. Sullivan DC, Mirmalek-Sani S-H, Deegan DB, et al. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials 2012; 33: 7756-7764.
36. Jiang W-C, Cheng Y-H, Yen M-H, et al. Cryo-chemical decellularization of the whole liver for mesenchymal stem cells-based functional hepatic tissue engineering. Biomaterials 2014; 35: 3607-3617.
37. Bao J, Shi Y, Sun H, et al. Construction of a portal implantable functional tissue-engineered liver using perfusion-decellularized matrix and hepatocytes in rats. Cell Transplant 2011; 20: 753-766.
38. Gilpin SE, Guyette JP, Gonzalez G, et al. Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale. J Heart Lung Transplant 2013; 33: 298-308.
39. Boyd WD, Johnson WE, Sultan PK, et al. Pericardial reconstruction using an extracellular matrix implant correlates with reduced risk of postoperative atrial fibrillation in coronary artery bypass surgery patients. Heart Surg Forum 2010; 2010: E311-E316. Carden Jennings.
40. Mostow EN, Haraway GD, Dalsing M, et al. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 2005; 41: 837-843.
41. Meyer SR, Chiu B, Churchill TA, et al. Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res, Part A 2006; 79: 254-262.
42. Ross EA, Williams MJ, Hamazaki T, et al. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 2009; 20: 2338-2347.
43. Shupe T, Williams M, Brown A, et al. Method for the decellularization of intact rat liver. Organogenesis 2010; 6: 134.
44. Ozeki M, Narita Y, Kagami H, et al. Evaluation of decellularized esophagus as a scaffold for cultured esophageal epithelial cells. J Biomed Mater Res, Part A 2006; 79: 771-778.
45. Funamoto S, Nam K, Kimura T, et al. The use of high-hydrostatic pressure treatment to decellularize blood vessels. Biomaterials 2010; 31: 3590-3595.
46. Cebotari S, Tudorache I, Jaekel T, et al. Detergent decellularization of heart valves for tissue engineering: toxicological effects of residual detergents on human endothelial cells. Artif Organs 2010; 34: 206-210.